Medicare's new $50 weight-loss drug program
Digest more
News Nation on MSN
Federal GLP-1 program could save billions: Dr. Oz
Dr. Oz hopes the program's data will reveal how many eligible beneficiaries choose to take the drugs.
If you’re considering taking a GLP-1 (glucagon-like peptide-1) receptor agonist for weight loss, here’s what to know about the long-term benefits and risks, along with insights from physicians. GLP-1 medications may have several benefits beyond just weight loss when treating obesity or overweight conditions,
For millions of people taking GLP-1 medications, the extreme heat can raise the risk of dehydration.
In a candid revelation, actress Mayim Bialik opened up about her distressing journey with GLP-1 medication, which brought on severe diarrhea and body aches that persisted for weeks. Originally prescribed for her autoimmune condition,
The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers have not been disclosed.
Big pharmaceutical companies argue that knock off GLP-1 drugs are misleading consumers and violating trade laws.
Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'
GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations among people with Type 2 diabetes who also had narrowed leg arteries associated with PAD (peripheral artery disease),
